Healthy Skepticism Library item: 3642

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

MaLAM letter follow up—Organon
MaLAM Newsletter 1988 Sep; 1

Abstract:

Organon continues to claim that high dose estrogen/progesterone combinations are useful and safe.

Keywords:
*analysis/developing countries/Organon/hormones/ oestradiol/ progesterone/company responses/quality of information/ safety & risk information/MaLAM/Medical Lobby for Appropriate Marketing/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: HORMONE REPLACEMENT THERAPY/REGULATION, CODES, GUIDELINES: FEEDBACK TO COMPANIES